Response to Biologics During the First Six Months of Therapy in Biologic-naïve Patients with Psoriasis Predicts Risk of Disease Flares: A Danish Nationwide Study

• Egile Nagusiak: Nikolai Loft (Egilea), Alexander Egeberg (Egilea), Mads Kirchheiner Rasmussen (Egilea), Lars Erik Bryld (Egilea), Christoffer V. Nissen (Egilea), Tomas Norman Dam (Egilea), Kawa Khaled Ajgeiy (Egilea), Lars Iversen (Egilea), Lone Skov (Egilea)
• Formatua: Liburua
• Argitaratua: Medical Journals Sweden, 2021-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Early response to treatment with biologics might be important for the stability of psoriasis and long-term outcome. The aim of this study was therefore to assess whether risk of flares and drug survival are associated with disease activity in the first 6 months of treatment of psoriasis with biologi...